Chino Hills, 05/18/2021 / 15:31, CET/CEST – EQS Newswire – Sohm, Inc.
CHINO HILLS, CA / ACCESSWIRE / May 18, 2021 / SOHM, Inc. (OTC PINK:SHMN), a generic pharmaceutical, nutraceutical, and cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, announced today its outlook for the year 2021.
Mr. Baron Night, CEO, announced today that the company management is very happy with the performance of Q1 financials. YoY revenue growth is 163% to$ 32,235, Gross profit has increased to 71% and profitability has increased 38.85% and YOY is $7413. The company continues to expect continuous growth during the Q2 and second half of the year with executing our previously announced orders.
The company has previously announced that it has received a mandate for prescription skin product orders and is in process of developing and subsequently delivering it to buyers. These products are expected to give the company regular repeat orders throughout the year.
The company has been in discussion and negotiation with the pharmaceutical acquisition as announced recently and hence it has put hold on its “Share Buy Back” as previously announced. The company plans to utilize the resources for the acquisition as well as for operation and development. Also, during the year 2020, due to a totally unforeseen expected year, the company decided to introduce some of its personal care products and work to capitalize on this market space. The personal…